Edgewell Personal Care (EPC) 10-Q 3 Aug 23 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jun. 30, 2023	Jul. 31, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	001-15401
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Incorporation, State or Country Code	MO
Entity Tax Identification Number	43-1863181
Entity Address, Address Line One	6 Research Drive
Entity Address, City or Town	Shelton,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06484
City Area Code	(203)
Local Phone Number	944-5500
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	EPC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		50,811,891
Entity Central Index Key	0001096752
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Net sales	$ 650	$ 623.8	$ 1,717.5	$ 1,634.8
Cost of products sold	370.3	383.2	1,007.1	974.2
Gross profit	279.7	240.6	710.4	660.6
Selling, general and administrative expense	96.3	92.7	297.2	290.9
Advertising and sales promotion expense	80	80.9	188.8	197
Research and development expense	14.8	13.6	42.6	40.1
Restructuring charges	3	3.5	8.7	9.2
Operating income	85.6	49.9	173.1	123.4
Interest expense associated with debt	19.2	18	59.8	53.3
Other (income) expense, net	(3.8)	(4.4)	0.7	(9.5)
Earnings before income taxes	70.2	36.3	112.6	79.6
Income tax provision	17.7	5.8	29.2	14.7
Net earnings	$ 52.5	$ 30.5	$ 83.4	$ 64.9
Basic net earnings per share	$ 1.03	$ 0.58	$ 1.62	$ 1.21
Diluted net earnings per share	$ 1.01	$ 0.57	$ 1.61	$ 1.20
Condensed Consolidated Statements of Comprehensive Income
Net earnings	$ 52.5	$ 30.5	$ 83.4	$ 64.9
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	7.5	(34.4)	67.6	(50.3)
Pension and postretirement activity, net of tax	(0.4)	0.7	3.9	0.8
Deferred gain (loss) on hedging activity, net of tax	1.8	3.1	(6.2)	4.5
Total other comprehensive income (loss), net of tax	8.9	(30.6)	65.3	(45)
Total comprehensive income (loss)	$ 61.4	$ (0.1)	$ 148.7	$ 19.9

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Earnings and Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Pension and postretirement activity, tax	$ (0.6)	$ 0.4	$ 0.9	$ 0.7
Deferred gain on hedging activity, tax	$ 0.9	$ 1.4	$ (2.8)	$ 2
Diluted net earnings per share	$ 1.01	$ 0.57	$ 1.61	$ 1.20

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2023	Sep. 30, 2022
Current assets
Cash and cash equivalents	$ 207.4	$ 188.7
Trade receivables, less allowance for doubtful accounts	121.5	136.9
Inventories	502.5	449.3
Other current assets	157.2	167.3
Total current assets	988.6	942.2
Property, plant and equipment, net	339.8	345.5
Goodwill	1,336.1	1,322.2
Other intangible assets, net	983.7	996.6
Other assets	118.1	106.6
Total assets	3,766.3	3,713.1
Current liabilities
Notes payable	17.7	19
Accounts payable	241.1	237.3
Other current liabilities	321	291.7
Total current liabilities	579.8	548
Long-term debt	1,323.1	1,391.4
Deferred income tax liabilities	142.3	140.4
Other liabilities	170	173.6
Liabilities, Total	2,215.2	2,253.4
Shareholders’ equity
Preferred shares	0	0
Common shares	0.7	0.7
Additional paid-in capital	1,586.3	1,604.3
Retained earnings	991.2	931.7
Common shares in treasury at cost	(876.3)	(860.9)
Accumulated other comprehensive loss	(150.8)	(216.1)
Total shareholders’ equity	1,551.1	1,459.7
Total liabilities and shareholders’ equity	$ 3,766.3	$ 3,713.1

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2023	Sep. 30, 2022
Statement of Financial Position [Abstract]
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	300,000,000	300,000,000
Common shares, issued (in shares)	65,251,989	65,251,989
Common shares, outstanding (in shares)	50,892,000	51,573,001
Treasury Stock, Common, Shares	14,359,989	13,678,988
Accounts Receivable, Allowance for Credit Loss	$ 6.2	$ 3.8

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash Flow from Operating Activities
Net earnings	$ 83.4	$ 64.9
Depreciation and amortization	68.1	67.1
Share-based compensation expense	19.8	18.4
Loss on sale of assets	1.1	0.6
Defined Benefit Plan, Benefit Obligation, Payment for Settlement	7.2
Deferred compensation payments	(4.9)	(7.1)
Deferred income taxes	(0.6)	(10.6)
Proceeds (payments) for other operating activities	7.8	(56.1)
Other, net	(13.6)	(4.8)
Net cash from operating activities	168.3	72.4
Cash Flow from Investing Activities
Capital expenditures	(31.1)	(37.4)
Acquisition of Billie, net of cash acquired	0	309.4
Collection of deferred purchase price on accounts receivable sold	1.5	5.6
Proceeds from sale of Infant and Pet Care business	(2)	(1.4)
Other, net	0	5
Net cash used by investing activities	(31.6)	(337.6)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	645	534
Cash payments on debt with original maturities greater than 90 days	(715)	(413)
Proceeds (payments) of debt with original maturities of 90 days or less	5.1	(4.3)
Repurchase of shares	(45.2)	(110.1)
Dividends to common shareholders	(23.8)	(24.7)
Net financing inflow from the Accounts Receivable Facility	9.6	6.5
Employee shares withheld for taxes	(9)	(10.4)
Proceeds (payments) for other financing activities	1	0.6
Net cash used by financing activities	(132.3)	(21.4)
Effect of exchange rate changes on cash	14.3	(11)
Net decrease in cash and cash equivalents	18.7	(297.6)
Cash and cash equivalents, beginning of period	188.7	479.2
Cash and cash equivalents, end of period	$ 207.4	$ 181.6

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Changes in Shareholders' Equity Statement - USD ($) $ in Millions	Total	Reclassification out of Accumulated Other Comprehensive Income	Other expense (income), net Reclassification out of Accumulated Other Comprehensive Income	Common shares	Treasury Stock, Common	Additional paid-in capital	Retained earnings	Accumulated other comprehensive loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, Common, Shares					(10,900,000)
Common shares, issued (in shares)				65,200,000
Treasury Stock, Common, Shares					(10,900,000)
Beginning shareholders' equity at Sep. 30, 2021	$ 1,584.3			$ 0.7	$ (776.3)	$ 1,631.1	$ 865.7	$ (136.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	11.2						11.2
Foreign currency translation adjustments	(6.9)							(6.9)
Deferred gain (loss) on hedging activity, net of tax	0.4							0.4
Dividends declared to common shareholders	(8.4)						(8.4)
Treasury shares repurchased (in usd)	(24.5)				$ (24.5)
Treasury shares repurchased (in shares)					(500,000)
Activity under share plans (shares)					300,000
Activity under share plans (in usd)	(3.8)				$ 33.6
APIC activity under share plans						(37.4)
Ending shareholders' equity at Dec. 31, 2021	1,552.3			0.7	(767.2)	1,593.7	868.5	(143.4)
Beginning shareholders' equity at Sep. 30, 2021	1,584.3			0.7	(776.3)	1,631.1	865.7	(136.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	64.9
Foreign currency translation adjustments	(50.3)
Pension and postretirement activity, net of tax	0.8
Deferred gain (loss) on hedging activity, net of tax	4.5
Ending shareholders' equity at Jun. 30, 2022	1,478.1			$ 0.7	$ (846.5)	1,599.9	905.9	(181.9)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax			$ 6.3
Treasury Stock, Common, Shares					(11,100,000)
Common shares, issued (in shares)				65,200,000
Treasury Stock, Common, Shares					(11,100,000)
Beginning shareholders' equity at Dec. 31, 2021	1,552.3			$ 0.7	$ (767.2)	1,593.7	868.5	(143.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	23.2						23.2
Foreign currency translation adjustments	(9)							(9)
Pension and postretirement activity, net of tax	0.1							0.1
Deferred gain (loss) on hedging activity, net of tax	1							1
Dividends declared to common shareholders	(8.2)						(8.2)
Treasury shares repurchased (in usd)	(50.9)				$ (50.9)
Treasury shares repurchased (in shares)					(1,400,000)
Activity under share plans (shares)					100,000
Activity under share plans (in usd)	7				$ 3.5
APIC activity under share plans						3.5
Ending shareholders' equity at Mar. 31, 2022	1,515.5			$ 0.7	$ (814.6)	1,597.2	883.5	(151.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, Common, Shares					(12,400,000)
Common shares, issued (in shares)				65,200,000
Treasury Stock, Common, Shares					(12,400,000)
Net earnings	30.5						30.5
Foreign currency translation adjustments	(34.4)							(34.4)
Pension and postretirement activity, net of tax	0.7							0.7
Deferred gain (loss) on hedging activity, net of tax	3.1							3.1
Dividends declared to common shareholders	(8.1)						(8.1)
Treasury shares repurchased (in usd)	(34.7)				$ (34.7)
Treasury shares repurchased (in shares)					(1,000,000)
Activity under share plans (shares)					100,000
Activity under share plans (in usd)	5.5				$ 2.8
APIC activity under share plans						2.7
Ending shareholders' equity at Jun. 30, 2022	$ 1,478.1			$ 0.7	$ (846.5)	1,599.9	905.9	(181.9)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax		$ 3.4
Treasury Stock, Common, Shares					(13,300,000)
Common shares, issued (in shares)				65,200,000
Treasury Stock, Common, Shares					(13,300,000)
Treasury Stock, Common, Shares	13,678,988				(13,700,000)
Common shares, issued (in shares)	65,251,989			65,200,000
Treasury Stock, Common, Shares	13,678,988				(13,700,000)
Beginning shareholders' equity at Sep. 30, 2022	$ 1,459.7			$ 0.7	$ (860.9)	1,604.3	931.7	(216.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	11.9						(11.9)
Foreign currency translation adjustments	48							48
Pension and postretirement activity, net of tax	(0.2)							(0.2)
Deferred gain (loss) on hedging activity, net of tax	(8.2)							(8.2)
Dividends declared to common shareholders	(8)						(8)
Treasury shares repurchased (in usd)	(15)				$ (15)
Treasury shares repurchased (in shares)					(400,000)
Activity under share plans (shares)					400,000
Activity under share plans (in usd)	(1.5)				$ 25
APIC activity under share plans						(26.5)
Ending shareholders' equity at Dec. 31, 2022	1,486.7			0.7	(850.9)	1,577.8	935.6	(176.5)
Beginning shareholders' equity at Sep. 30, 2022	1,459.7			0.7	(860.9)	1,604.3	931.7	(216.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	83.4
Foreign currency translation adjustments	67.6
Pension and postretirement activity, net of tax	3.9
Deferred gain (loss) on hedging activity, net of tax	(6.2)
Treasury shares repurchased (in usd)	$ (45.2)
Treasury shares repurchased (in shares)	(1,100,000)
Ending shareholders' equity at Jun. 30, 2023	$ 1,551.1			$ 0.7	$ (876.3)	1,586.3	991.2	(150.8)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax			$ 6.8
Treasury Stock, Common, Shares					(13,700,000)
Common shares, issued (in shares)				65,200,000
Treasury Stock, Common, Shares					(13,700,000)
Beginning shareholders' equity at Dec. 31, 2022	1,486.7			$ 0.7	$ (850.9)	1,577.8	935.6	(176.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	19						19
Foreign currency translation adjustments	12.1							12.1
Pension and postretirement activity, net of tax	4.5							4.5
Deferred gain (loss) on hedging activity, net of tax	0.2							0.2
Dividends declared to common shareholders	(8.2)						(8.2)
Treasury shares repurchased (in usd)	(15)				$ (15)
Treasury shares repurchased (in shares)					(400,000)
Activity under share plans (shares)					0
Activity under share plans (in usd)	7.7				$ 2.3
APIC activity under share plans						5.4
Ending shareholders' equity at Mar. 31, 2023	1,507			$ 0.7	$ (863.6)	1,583.2	946.4	(159.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, Common, Shares					(14,100,000)
Common shares, issued (in shares)				65,200,000
Treasury Stock, Common, Shares					(14,100,000)
Net earnings	52.5						52.5
Foreign currency translation adjustments	7.5							7.5
Pension and postretirement activity, net of tax	(0.4)							(0.4)
Deferred gain (loss) on hedging activity, net of tax	1.8							1.8
Dividends declared to common shareholders	(7.7)						(7.7)
Treasury shares repurchased (in usd)	(15.2)				$ (15.2)
Treasury shares repurchased (in shares)					(300,000)
Activity under share plans (shares)					0
Activity under share plans (in usd)	5.6				$ 2.5
APIC activity under share plans						3.1
Ending shareholders' equity at Jun. 30, 2023	$ 1,551.1			$ 0.7	$ (876.3)	$ 1,586.3	$ 991.2	$ (150.8)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax		$ 1
Treasury Stock, Common, Shares	14,359,989				(14,400,000)
Common shares, issued (in shares)	65,251,989			65,200,000
Treasury Stock, Common, Shares	14,359,989				(14,400,000)

Background and Basis of Present

Background and Basis of Presentation	9 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Background Edgewell Personal Care Company and its subsidiaries (collectively, “Edgewell” or the “Company”) is one of the world’s largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, and feminine care categories. With operations in over 20 countries, our products are widely available in more than 50 countries. The Company conducts its business in the following three segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge, Skintimate®, Billie®, Shave Guard and Personna® brands, as well as non-branded products. The Company’s wet shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black®, Bulldog® and Cremo® men’s grooming products, Billie women’s grooming products and Wet Ones® products. • Feminine Care includes tampons, pads, and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree®, and o.b.® brands. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) under the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair statement have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 16, 2022. Acquisition of Billie, Inc. On November 29, 2021 (“the Acquisition Date”), the Company completed the acquisition of Billie, Inc. (“Billie”) (the “Acquisition”), a leading U.S. based consumer brand company that offers a broad portfolio of personal care products for women. The results of Billie for the post-acquisition period are included within the Company’s results since the Acquisition Date. For more information on the Acquisition, see Note 2 of Notes to Condensed Consolidated Financial Statements.

Business Combinations

Business Combinations	9 Months Ended
	Jun. 30, 2023
Business Combinations [Abstract]
Business Combinations and Divestitures	Business Combinations Billie Inc. The Company completed the Acquisition for cash consideration of $309.4, net of cash acquired. As a result of the Acquisition, Billie became a wholly owned subsidiary of the Company. The Company accounted for the Acquisition utilizing the acquisition method of accounting, which requires assets and liabilities to be recognized based on estimates of their acquisition date fair values. The determination of the values of the acquired assets and assumed liabilities, including goodwill, other intangible assets and deferred taxes, requires significant judgement. The Company has calculated fair values of the assets and liabilities acquired from Billie, including goodwill, intangible assets and working capital. The Company completed the final fair value determination of the Acquisition in the fourth quarter of fiscal year 2022. The Company used variations of the income approach in determining the fair value of intangible assets acquired in the Acquisition. Specifically, the Company utilized the multi-period excess earnings method to determine the fair value of the definite lived customer relationships acquired and the relief from royalty method to determine the fair value of the definite lived trade name acquired. The Company’s determination of the fair value of the intangible assets acquired involved the use of significant estimates and assumptions related to revenue growth rates, discount rates, customer attrition rates, and royalty rates. The Company believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use. The following table provides the allocation of the purchase price related to the Acquisition based upon the fair value of assets and liabilities assumed: Current assets $ 17.0 Goodwill 181.2 Intangible assets 136.0 Other assets, including property, plant and equipment, net 3.2 Current liabilities (6.9) Deferred tax liabilities (21.1) Cash consideration, net of cash acquired $ 309.4 The acquired goodwill represented the value of expansion into new categories, markets and channels of trade and is not deductible for tax purposes. The intangible assets acquired consisted primarily of the Billie trade name and customer relationships with a weighted average useful life of 19 years. All assets are included in the Company’s Wet Shave segment. The following summarizes the Company's unaudited pro forma consolidated results of operations for the three and nine months ended June 30, 2022, as though the Acquisition occurred on October 1, 2020. The three and nine months ended June 30, 2023 include results of Billie over the full periods presented. Three Months Ended Nine Months Ended June 30, 2022 Pro forma net sales $ 623.8 $ 1,644.8 Pro forma net earnings 31.6 70.3 The unaudited pro forma consolidated results of operations were adjusted by pre-tax amortization expense of $1.3 for the nine months ended June 30, 2022. Additionally, pro forma earnings for the three and nine months ended June 30, 2022 exclude $0.9 and $8.0 of pre-tax acquisition costs, respectively, as these costs would have been incurred in the prior year. The pro forma earnings were also adjusted to reflect the capital structure as of the Acquisition Date, and all pro forma adjustments have been included with related tax effects. The unaudited pro forma consolidated results of operations is not necessarily indicative of the results obtained had the Acquisition occurred on October 1, 2020, or of those results that may be obtained in the future. Amounts do not reflect any anticipated cost savings or cross-selling opportunities expected to result from the Acquisition.

Restructuring Charges

Restructuring Charges	9 Months Ended
	Jun. 30, 2023
Restructuring Charges [Abstract]
Restructuring Charges	Restructuring Charges Operating Model Redesign In fiscal 2023, the Company is continuing to take actions to strengthen its operating model, simplify the organization and improve manufacturing and supply chain efficiency and productivity. As a result of these actions, the Company expects to incur restructuring and related charges of approximately $18 in fiscal 2023. To date the Company has incurred restructuring and related charges as follows: Three Months Ended June 30, 2023 Three Months Ended June 30, 2022 Nine Months Ended June 30, 2023 Nine Months Ended June 30, 2022 Severance and related benefit costs $ 1.3 $ 1.0 $ 4.1 $ 4.0 Asset write-off and accelerated depreciation 0.1 0.3 0.3 0.4 Consulting, project implementation and management, and other exit costs 1.7 2.6 4.7 5.4 Total restructuring and related costs (1)(2) $ 3.1 $ 3.9 $ 9.1 $ 9.8 (1) Restructuring and related co sts of nil and $0.2 are included within Cost of products sold for the three and nine months ended June 30, 2023, respectively. (2) Restructuring and related costs of $0.1 and $0.2 are included within Selling, general and administrative expense (“SG&A”) for the three and nine months ended June 30, 2023, respectively, and $0.4 and $0.6 for the three and nine months ended June 30, 2022, respectively. The following table summarizes the restructuring activities and related accrual for the nine months ended June 30, 2023: Utilized October 1, 2022 Charge to Cash June 30, Severance and related benefit costs $ 1.7 $ 4.1 $ (4.7) $ 1.1 Asset write-off and accelerated depreciation — 0.3 (0.3) — Consulting, project implementation and management, and other exit costs 0.8 4.7 (5.4) 0.1 Total restructuring activities and related accrual $ 2.5 $ 9.1 $ (10.4) $ 1.2

Earnings per Share

Earnings per Share	9 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic earnings per share is based on the weighted-average number of common shares outstanding during the period. Diluted earnings per share is based on the number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options, restricted share equivalent (“RSE”) and performance restricted share equivalent (“PRSE”) awards. The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Basic weighted-average shares outstanding 51.1 52.5 51.3 53.5 Effect of dilutive securities: Options, RSE and PRSE awards 0.7 0.6 0.6 0.6 Total dilutive securities 0.7 0.6 0.6 0.6 Diluted weighted-average shares outstanding 51.8 53.1 51.9 54.1 For the three and nine months ended June 30, 2023, the calculation of diluted weighted-average shares outstanding excludes 0.8 and 1.0, respectively, of share options and nil and nil, respectively, of RSE and PRSE awards because the effect of including these awards was anti-dilutive. For both the three and nine months ended June 30, 2022, the calculation of diluted weighted-average shares outstanding excludes 1.0 of share options. For the three and nine months ended June 30, 2022, the calculation excludes 0.5 and 0.3, respectively, of RSE and PRSE awards because the effect of including these awards was anti-dilutive.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table sets forth goodwill by segment: Wet Sun and Skin Feminine Total Gross balance as of October 1, 2022 $ 1,133.5 $ 354.5 $ 205.2 $ 1,693.2 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance as of October 1, 2022 $ 764.5 $ 352.5 $ 205.2 $ 1,322.2 Changes in the nine months ended June 30, 2023 Cumulative translation adjustment 10.1 2.0 1.8 13.9 Gross balance as of June 30, 2023 $ 1,143.6 $ 356.5 $ 207.0 $ 1,707.1 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance as of June 30, 2023 $ 774.6 $ 354.5 $ 207.0 $ 1,336.1 The following table sets forth intangible assets by class: June 30, 2023 September 30, 2022 Carrying Accumulated Net Carrying Accumulated Net Indefinite lived Trade names and brands $ 595.4 $ — $ 595.4 $ 587.1 $ — $ 587.1 Amortizable Trade names and brands $ 339.7 $ 84.3 $ 255.4 $ 339.4 $ 72.2 $ 267.2 Technology and patents 78.6 76.1 2.5 77.8 75.0 2.8 Customer related and other 271.2 140.8 130.4 267.1 127.5 139.6 Amortizable intangible assets 689.5 301.2 388.3 684.3 274.7 409.5 Total intangible assets $ 1,284.9 $ 301.2 $ 983.7 $ 1,271.4 $ 274.7 $ 996.6 Amortization expense was $7.8 and $23.2 f or the three and nine months ended June 30, 2023, respectively, and $7.8 and $21.8 for the three and nine months ended June 30, 2022, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2023 and for fiscal 2024, 2025, 2026, 2027 and 2028 is $7.7, $30.8, $30.7, $30.5, $30.5 and $30.4, respectively, and $227.7 t hereafter. Goodwill and intangible assets deemed to have an indefinite life are not amortized but are instead reviewed annually for impairment or when indicators of a potential impairment are present. The Company’s annual impairment testing date is July 1. An interim impairment analysis may indicate that carrying amounts of goodwill and other intangible assets require adjustment or that remaining useful lives should be revised. The Company determined there was no triggering event requiring an interim impairment analysis during the nine months ended June 30, 2023.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	9 Months Ended
	Jun. 30, 2023
Supplemental Balance Sheet Information [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information June 30, September 30, Inventories Raw materials and supplies $ 88.8 $ 80.4 Work in process 95.8 103.2 Finished products 317.9 265.7 Total inventories $ 502.5 $ 449.3 Other Current Assets Prepaid expenses $ 73.4 $ 70.2 Value added tax receivables 48.0 52.7 Income taxes receivable 20.7 19.3 Other 15.1 25.1 Total other current assets $ 157.2 $ 167.3 Property, Plant and Equipment Land $ 18.7 $ 18.0 Buildings 142.8 140.3 Machinery and equipment 1,103.9 1,050.0 Capitalized software costs 59.4 56.5 Construction in progress 38.9 47.0 Total gross property, plant and equipment 1,363.7 1,311.8 Accumulated depreciation and amortization (1,023.9) (966.3) Total property, plant and equipment, net $ 339.8 $ 345.5 Other Current Liabilities Accrued advertising and sales promotion $ 55.2 $ 34.9 Other 265.8 256.8 Total other current liabilities $ 321.0 $ 291.7 Other Liabilities Pensions and other retirement benefits $ 58.8 $ 57.9 Other 111.2 115.7 Total other liabilities $ 170.0 $ 173.6

Leases

Leases	9 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Leases	Leases The Company leases certain offices and manufacturing facilities, warehouses, employee vehicles and certain manufacturing related equipment and determines if an arrangement is or contains a lease at inception. Leases may include options to extend or terminate the lease, and those options are recorded on the Condensed Consolidated Balance Sheet when it is reasonably certain that the Company will exercise one of those options. All recorded leases are classified as operating leases, and lease expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheet. A summary of the Company's lease information is as follows: June 30, September 30, Assets Classification Right of use assets Other assets $ 49.1 $ 50.1 Liabilities Current lease liabilities Other current liabilities $ 8.6 $ 8.8 Long-term lease liabilities Other liabilities 41.0 41.5 Total lease liabilities $ 49.6 $ 50.3 Other information Weighted-average remaining lease term (years) 11 10 Weighted-average incremental borrowing rate 7.0 % 6.6 % Three Months Ended Nine Months Ended 2023 2022 2023 2022 Statement of Earnings Lease expense (1) $ 3.0 $ 3.7 $ 9.1 $ 10.5 Other information Leased assets obtained in exchange for new lease liabilities $ 0.5 $ 1.0 $ 2.0 $ 3.9 Cash paid for amounts included in the measurement of lease liabilities $ 3.0 $ 3.7 $ 9.0 $ 10.7 (1) Lease expense is included in Cost of products sold or SG&A expense based on the nature of the lease. Short-term lease expense is not considered material and is, therefore, excluded from this amount. The Company's future lease payments, including reasonably assured renewal options under leases, are as follows: Lease liability repayments June 30, 2023 Remainder of fiscal 2023 $ 2.7 2024 10.3 2025 9.4 2026 8.0 2027 6.2 2028 and thereafter 40.4 Total future minimum lease commitments 77.0 Less: Imputed interest (27.4) Present value of lease liabilities $ 49.6

Accounts Receivable Facility

Accounts Receivable Facility	3 Months Ended
	Jun. 30, 2023
Transfers and Servicing [Abstract]
Accounts receivable facility	Accounts Receivable Facilities The Company participates in accounts receivable facility programs both in the United States and Japan. These receivable agreements are between the Company and MUFG Bank, LTD, and the subsidiaries of both parties. Transfers under the accounts receivable repurchase agreements are accounted for as sales of accounts receivables, resulting in the receivables being derecognized from the Condensed Consolidated Balance Sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign, transfer, or participate any of its rights under the purchased receivables to another bank or financial institution. The purchase and sale of receivables under accounts receivable repurchase agreements is intended to be an absolute and irrevocable transfer without recourse by the purchaser to the Company for the creditworthiness of any obligor. The Company has considered its performance obligation to collect and service the receivables sold in the United States and Japan and has determined that such services are not material. The compensation received is considered acceptable servicing compensation and as such, the Company does not recognize a servicing asset or liability. Accounts receivables sold were $388.7 and $916.3 for the three and nine months ended June 30, 2023, respectively, and $354.0 and $791.2 for the three and nine months ended June 30, 2022, respectively. The trade receivables sold that remained outstanding as of June 30, 2023 and September 30, 2022 were $164.6 and $78.7, respectively. The net proceeds received were included in both Cash from operating activities and Cash used by investing activities on the Condensed Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in Other (income) expense, net in the Condensed Consolidated Statements of Earnings and Comprehensive Income. The loss on sale of trade receivables was $2.1 and $4.5 for the three and nine months ended June 30, 2023, respectively, and $0.6 and $1.1 for the three and nine months ended June 30, 2022, respectively.

Debt

Debt	9 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Debt	Debt The detail of long-term debt was as follows: June 30, September 30, Senior notes, fixed interest rate of 5.500%, due 2028 $ 750.0 $ 750.0 Senior notes, fixed interest rate of 4.125%, due 2029 500.0 500.0 U.S. revolving credit facility (1) 85.0 155.0 Total 1,335.0 1,405.0 Less unamortized debt issuance costs and discount (2) 11.9 13.6 Total long-term debt $ 1,323.1 $ 1,391.4 (1) The U.S. revolving credit facility matures in April 2025. (2) As of June 30, 2023, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $7.2 and $4.7, respectively. As of September 30, 2022, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $8.3 and $5.3, respectively. Additionally, the Company had variable-rate international borrowings, recorded in Notes payable, of $17.7 a nd $19.0 as of June 30, 2023 and September 30, 2022, respectively. Senior Secured Revolving Credit Facility On February 6, 2023, the Company amended its senior secured revolving credit facility in an aggregate principal amount of $425.0 dated March 28, 2020 between the Company and Bank of America, N.A., as administrative agent, and lenders parties thereto (the “Revolving Credit Facility”), to reflect the required transaction from the London Interbank Offered Rate (“LIBOR”) to the Secured Overnight Financing Rate (“SOFR”) as the dominant benchmark rate by June 30, 2023. This did not have a material change on interest expense for the period ended June 30, 2023.

Retirement Plans

Retirement Plans	9 Months Ended
	Jun. 30, 2023
Retirement Benefits [Abstract]
Retirement Plans	Retirement PlansThe Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries. The plans provide retirement benefits based on years of service and compensation. The Company also sponsors or participates in several other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below. The Company’s net periodic pension and postretirement costs (income) for its material plans were as follows: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Service cost $ 0.5 $ 0.9 $ 1.4 $ 2.9 Interest cost 5.3 2.6 15.9 7.8 Expected return on plan assets (5.4) (5.3) (16.3) (15.9) Recognized net actuarial loss 0.4 1.5 1.2 4.6 Defined benefit settlement loss — — 7.2 — Net periodic cost (income) $ 0.8 $ (0.3) $ 9.4 $ (0.6) The service cost component of the net periodic cost (income) associated with the Company’s retirement plans is recorded to Cost of products sold and SG&A on the Condensed Consolidated Statement of Earnings and Comprehensive Income. The remaining net periodic cost (income) is recorded to Other (income) expense, net on the Condensed Consolidated Statement of Earnings and Comprehensive Income. The Company initiated the wind-up of its Canadian defined benefit pension plan (“Canada Plan”) in June 2021. On September 1, 2021, Edgewell Personal Care Canada ULC (“EPC Canada”) as administrator of the Canada Plan entered into a buy-in annuity purchase agreement (“Buy-in Agreement”) with Brookfield Annuity Company (“Brookfield Annuity”) for certain members of the Canada Plan. On January 25, 2023, the Company received approval by the Financial Services Regulatory Authority of Ontario to wind-up the Canada Plan. Upon regulatory approval of the Canada Plan, EPC Canada proceeded with purchasing annuities for the remaining Canada Plan participants and converting the Buy-in Agreement to a buy-out annuity purchase agreement (“Buy-out Agreement”), which was purchased and funded by the Canada Plan on March 31, 2023. The Company was relieved of its defined benefit pension obligation through its irrevocable commitment under the Buy-out Agreement. As of the settlement date, the Company remeasured its assets and its projected benefit obligation associated with the Canada Plan. Upon settlement, the Company derecognized the assets, projected benefit obligation and losses remaining in accumulated other comprehensive loss (“AOCI”) associated with the Canada Plan, which resulted in a loss on settlement of $7.2. The loss was recorded in Other (income) expense, net on the Condensed Consolidated Statement of Earnings and Comprehensive Income for the nine months ended June 30, 2023.

Equity

Equity	9 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Shareholders' Equity	Shareholders’ Equity Share Repurchases In January 2018, the Company’s Board of Directors (the “Board”) authorized the repurchase of up to 10.0 shares of the Company’s common stock, replacing the previous share repurchase authorization from May 2015. The Company repurchased 1.1 shares of its common stock for $45.2 during the nine months ended June 30, 2023. There are 5.4 shares of common stock available for repurchase in the future under the Board’s authorization as of June 30, 2023. Any future share repurchases may be made in the open market, privately negotiated transactions, or otherwise permitted, and in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs, and other factors. Dividends On November 3, 2022, the Board declared a quarterly cash dividend of $0.15 per common share for the fourth fiscal quarter of 2022. The dividend was paid on January 4, 2023 to shareholders of record as of the close of business on November 29, 2022. On February 3, 2023, the Board declared a quarterly cash dividend of $0.15 per common share for the first fiscal quarter of 2023. The dividend was paid on April 5, 2023 to stockholders of record as of the close of business on March 8, 2023. On May 8, 2023, the Board declared a quarterly cash dividend of $0.15 per common share for the second fiscal quarter of 2023. The dividend was paid on July 6, 2023 to stockholders of record as of the close of business on June 7, 2023. On August 1, 2023, the Board declared a quarterly cash dividend of $0.15 per common share for the third fiscal quarter of 2023. The dividend will be payable on October 4, 2023 to shareholders of record as the close of business on September 7, 2023. Dividends declared during the nine months ended June 30, 2023 totaled $23.9. Payments made for dividends during the nine months ended June 30, 2023 totaled $23.8.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Jun. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The following table presents the changes in AOCI, net of tax, by component: Foreign Pension and Hedging Total Balance as of October 1, 2022 $ (131.2) $ (92.6) $ 7.7 $ (216.1) Other comprehensive income (loss), net of tax 67.6 (2.3) (1.5) 63.8 Reclassifications to earnings — 6.2 (4.7) 1.5 Balance as of June 30, 2023 $ (63.6) $ (88.7) $ 1.5 $ (150.8) Foreign Pension and Hedging Total Balance as of October 1, 2021 $ (41.8) $ (97.3) $ 2.2 $ (136.9) Other comprehensive (loss) income, net of tax (50.3) (2.6) 8.7 (44.2) Reclassifications to earnings — 3.4 (4.2) (0.8) Balance as of June 30, 2022 $ (92.1) $ (96.5) $ 6.7 $ (181.9) The following table presents the reclassifications out of AOCI: Three Months Ended Nine Months Ended Affected Line Item in the Details of AOCI Components 2023 2022 2023 2022 Gain / (Loss) on cash flow hedges Foreign exchange contracts $ 1.0 $ 3.4 $ 6.8 $ 6.3 Other (income) expense, net Income tax expense (benefit) 0.3 1.1 2.1 2.1 Income tax provision 0.7 2.3 4.7 4.2 Amortization of defined benefit pension and postretirement items Actuarial losses (1) $ (0.4) $ (1.5) $ (1.2) $ (4.6) Defined benefit settlement loss — — (7.2) — Other (income) expense, net Income tax expense (benefit) (0.1) (0.4) (2.2) (1.2) Income tax provision (0.3) (1.1) (6.2) (3.4) Total reclassifications for the period $ 0.4 $ 1.2 $ (1.5) $ 0.8 (1) These AOCI components are included in the computation of net periodic cost. See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Risk

Financial Instruments and Risk Management	9 Months Ended
	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management In the ordinary course of business, the Company may enter into contractual arrangements (also referred to as derivatives) to reduce its exposure to foreign currency. The Company has master netting agreements with all of its counterparties that allow for the settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties, and its counterparty netting arrangements. The section below outlines the types of derivatives in place as of June 30, 2023 and September 30, 2022, as well as the Company’s objectives and strategies for holding derivative instruments. Foreign Currency Risk A significant share of the Company’s sales is tied to currencies other than the U.S. dollar, the Company’s reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have an unfavorable impact on reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the euro, the Japanese yen, the British pound, the Canadian dollar, and the Australian dollar. Additionally, the Company’s foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary’s local currency at the end of each month. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary’s local currency results in an exchange gain or loss recorded in Other (income) expense, net. The primary currency to which the Company’s foreign subsidiaries are exposed is the U.S. dollar. Cash Flow Hedges As of June 30, 2023, the Company maintained a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective by the Company for accounting purposes in offsetting the associated risk. The Company has forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had unrealized pre-tax gains of $2.4 and $11.3 as of June 30, 2023 and September 30, 2022, respectively, on these forward currency contracts, which are accounted for as cash flow hedges and included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at June 30, 2023 levels over the next 12 months, the majority of the pre-tax gain included in AOCI as of June 30, 2023 is expected to be included in Other (income) expense, net. Contract maturities for these hedges extend into fiscal 2025. As of June 30, 2023, there were 64 open foreign currency contracts with a total notional value of $107.6. Derivatives not Designated as Hedges The Company has foreign currency derivative contracts, which are not designated as cash flow hedges for accounting purposes, to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures and, thus, are not expected to be subject to significant market risk. The change in the estimated fair value of the foreign currency contracts for the three and nine months ended June 30, 2023, resulted in a gains of $ 3.7 1.7 0.3 2.0 The following table provides estimated fair values of derivative instruments: Fair Value of Assets (Liabilities) as of (1) June 30, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 2.4 $ 11.3 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 1.5 $ 2.0 (1) Derivative assets are presented in Other current assets or Other assets. Derivative liabilities are presented in Other current liabilities or Other liabilities. The following table provides the pre-tax amounts of gains and losses on derivative instruments: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in OCI (1) $ 3.7 $ 7.8 $ (2.1) $ 12.7 Gain reclassified from AOCI into income (1) (2) 1.0 3.4 6.8 6.3 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ 3.7 $ 0.3 $ 1.7 $ 2.0 (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk. (2) Gain was recorded in Other (income) expense, net. The following table provides financial assets and liabilities for balance sheet offsetting: As of June 30, 2023 As of September 30, 2022 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 5.5 $ (1.8) $ 13.4 $ (0.5) Gross amounts offset in the balance sheet — 0.2 — 0.4 Net amounts of assets (liabilities) presented in the balance sheet $ 5.5 $ (1.6) $ 13.4 $ (0.1) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities. Fair Value Hierarchy Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs from inactive markets. The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: June 30, September 30, Assets (Liabilities) at estimated fair value: Deferred compensation liability $ (19.3) $ (21.8) Derivatives - foreign currency contracts (liability) asset 3.9 13.3 Net liabilities at estimated fair value $ (15.4) $ (8.5) The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan. As of June 30, 2023 and September 30, 2022, the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates, and remaining maturities. As of June 30, 2023 and September 30, 2022, the Company had no Level 1 financial assets or liabilities, other than pension plan assets, and no Level 3 financial assets or liabilities as of June 30, 2023 and September 30, 2022, respectively. As of June 30, 2023 and September 30, 2022, the fair market value of fixed rate long-term debt was $1,010.1 and $945.9, respectively, compared to its carrying value of $1,250.0 in each period. The estimated fair value of the long-term debt was estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of long-term debt, excluding the the Revolving Credit Facility, has been determined based on Level 2 inputs.

Segment Data

Segment Data	9 Months Ended
	Jun. 30, 2023
Segment Reporting [Abstract]
Segment Data	Segment Data For an overview of the Company’s segments, refer to Note 1 of the Notes to Condensed Consolidated Financial Statements. Segment performance is evaluated based on segment profit, excluding certain U.S. GAAP items that management does not believe are indicative of ongoing operating performance. These items include general corporate expenses, share-based compensation costs, amortization of intangible assets and certain other items, including restructuring and related costs, acquisition and integration costs, Sun Care reformulation costs, value-added tax settlement costs, loss on defined benefit settlement, income from resolution of legal matters, and at times management excludes other costs or income. Financial items, such as interest income and expense, are managed on a global basis at the corporate level and therefore are excluded from segment profit. The exclusion of such charges from segment results reflects management’s view on how management monitors and evaluates segment operating performance, generates future operating plans and makes strategic decisions regarding the allocation of capital. The Company’s operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, combined sales force and management teams. The Company applies a fully allocated cost basis in which shared business functions are allocated between the segments. Segment net sales and profitability are presented below: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Net Sales Wet Shave $ 324.1 $ 326.3 $ 908.0 $ 917.4 Sun and Skin Care 244.9 216.2 567.5 504.3 Feminine Care 81.0 81.3 242.0 213.1 Total net sales $ 650.0 $ 623.8 $ 1,717.5 $ 1,634.8 Segment Profit Wet Shave $ 32.1 $ 37.5 $ 102.6 $ 116.6 Sun and Skin Care 61.1 46.6 114.1 92.6 Feminine Care 13.9 8.8 37.7 19.1 Total segment profit 107.1 92.9 254.4 228.3 General corporate and other expenses (15.8) (14.8) (48.7) (42.8) Amortization of intangibles (7.8) (7.8) (23.2) (21.8) Interest and other expense, net (15.4) (13.6) (53.3) (43.8) Restructuring and related costs (1) (3.1) (3.9) (8.9) (9.8) Acquisition and integration costs (2) (1.0) (0.9) (5.1) (8.0) Sun Care reformulation costs (3) (0.6) (0.6) (1.7) (4.1) Defined benefit settlement loss (4) — — (7.2) — VAT settlement costs (5) — — — (3.4) Legal matters, net income (expense) (6) 6.8 7.5 6.3 7.5 SKU rationalization charges (7) — (22.5) — (22.5) Total earnings before income taxes $ 70.2 $ 36.3 $ 112.6 $ 79.6 (1) Restructuring and related costs of nil and $0.2 are included within Cost of products sold for the three and nine months ended June 30, 2023, respectively. Includes pre-tax SG&A of $0.1 and $0.2 for the three and nine months ended June 30, 2023, respectively and $0.4 and $0.6 for the three and nine months ended June 30, 2022. (2) Includes pre-tax SG&A of $0.9 and $7.2 for the three and nine months ended June 30, 2022, respectively, for the Acquisition. Additionally, includes Cost of products sold of $0.8 related to the valuation of acquired inventory for the Acquisition for the nine months ended June 30, 2022. See Note 2 of the Notes to Condensed Consolidated Financial Statements. (3) Includes pre-tax R&D of $0.6 and $1.7 for the three and nine months ended June 30, 2023, respectively, and pre-tax R&D of $0.6 for both the three and nine months ended June 30, 2022. Additional, includes pre-tax Cost of products sold of $3.5 for the nine months ended June 30, 2022 related to the reformulation, recall and destruction of certain Sun Care products. (4) Includes pre-tax loss of $7.2 for the nine months ended June 30, 2023 related the settlement of the Canada Plan. See Note 11 of the Notes to Condensed Consolidated Financial Statements. (5) Includes pre-tax SG&A of $3.4 for the nine months ended June 30, 2022 related to the estimated settlement of a prior years’ value-added tax audit of the Company’s German subsidiary. (6) Includes pre-tax SG&A of $7.1 for both the three and nine months ended June 30, 2023 and $7.5 for both the three and nine months ended June 30, 2022 for the favorable resolution of legal matters. See Note 16 of the Notes to Condensed Consolidated Financial Statements. Also includes other costs of $0.3 and $0.8 for the three and nine months ended June 30, 2023. (7) Includes pre-tax COGS of $22.5 for the three and nine months ended June 30, 2022 for the write-off of certain Wet Ones SKUs and related contract termination charges. Wet one products are included within the Sun and Skin Care segment. The following table presents the Company’s net sales by geographic area: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Net Sales to Customers United States $ 391.6 $ 392.8 $ 1,031.3 $ 997.2 International 258.4 231.0 686.2 637.6 Total net sales $ 650.0 $ 623.8 $ 1,717.5 $ 1,634.8 Supplemental product information is presented below for net sales: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Razors and blades $ 291.2 $ 290.1 $ 816.6 $ 821.1 Tampons, pads, and liners 81.0 81.3 242.0 213.1 Sun care products 184.2 162.4 385.8 334.0 Grooming products 38.2 33.9 123.5 114.6 Wipes and other skin care 22.5 19.9 58.2 55.7 Shaving gels and creams 32.9 36.2 91.4 96.3 Total net sales $ 650.0 $ 623.8 $ 1,717.5 $ 1,634.8

Commitment and Contingencies

Commitment and Contingencies	3 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure	Commitments and Contingencies Legal Proceedings During the three months ended June 30, 2023 the Company settled a legal matter which resulted in a gain of $4.9 related to an intellectual property claim against a third party. This was included in SG&A in the Condensed Consolidated Statements of Earnings and Comprehensive Income . The Company received payment for the intellectual property claim settlement during the three months ended June 30, 2023. Additionally, during the three months ended June 30, 2023, the Company received a favorable court ruling regarding an international VAT matter, which the plaintiff has no ability to appeal. As the Company had previously recorded an accrual for this matter, based on its best estimate of the facts and circumstances at that time, the result of the favorable court ruling was a release of the reserve established which resulted in a gain of $2.2. This was included in SG&A in the Condensed Consolidated Statements of Ear nings and Comprehensive Income . During the three months ended June 30, 2022 the Company settled certain legal matters which resulted in a gain of $7.5 related to intellectual property claims against a third party. This was included in SG&A in the Condensed Consolidated Statements of Earnings and Comprehensive Income . The Company received payment for the settlement subsequent to June 30, 2022.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2023	Jun. 30, 2022
Pay vs Performance Disclosure
Net earnings	$ 52.5	$ 19	$ 11.9	$ 30.5	$ 23.2	$ 11.2	$ 83.4	$ 64.9

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2023
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false

Organization, Consolidation and

Organization, Consolidation and Presentation of Financial Statements (Policies)	9 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Description and Basis of Presentation	Edgewell Personal Care Company and its subsidiaries (collectively, “Edgewell” or the “Company”) is one of the world’s largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, and feminine care categories. With operations in over 20 countries, our products are widely available in more than 50 countries. The Company conducts its business in the following three segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge, Skintimate®, Billie®, Shave Guard and Personna® brands, as well as non-branded products. The Company’s wet shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black®, Bulldog® and Cremo® men’s grooming products, Billie women’s grooming products and Wet Ones® products. • Feminine Care includes tampons, pads, and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree®, and o.b.® brands.
Basis of Accounting, Policy	Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) under the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair statement have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 16, 2022.

Business Combinations (Tables)

Business Combinations (Tables)	9 Months Ended
	Jun. 30, 2023
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table provides the allocation of the purchase price related to the Acquisition based upon the fair value of assets and liabilities assumed: Current assets $ 17.0 Goodwill 181.2 Intangible assets 136.0 Other assets, including property, plant and equipment, net 3.2 Current liabilities (6.9) Deferred tax liabilities (21.1) Cash consideration, net of cash acquired $ 309.4

Restructuring Charges (Tables)

Restructuring Charges (Tables)	9 Months Ended
	Jun. 30, 2023
Restructuring Charges [Abstract]
Schedule of Charges Related to Restructuring Activities	Three Months Ended June 30, 2023 Three Months Ended June 30, 2022 Nine Months Ended June 30, 2023 Nine Months Ended June 30, 2022 Severance and related benefit costs $ 1.3 $ 1.0 $ 4.1 $ 4.0 Asset write-off and accelerated depreciation 0.1 0.3 0.3 0.4 Consulting, project implementation and management, and other exit costs 1.7 2.6 4.7 5.4 Total restructuring and related costs (1)(2) $ 3.1 $ 3.9 $ 9.1 $ 9.8 (1) Restructuring and related co sts of nil and $0.2 are included within Cost of products sold for the three and nine months ended June 30, 2023, respectively. (2) Restructuring and related costs of $0.1 and $0.2 are included within Selling, general and administrative expense (“SG&A”) for the three and nine months ended June 30, 2023, respectively, and $0.4 and $0.6 for the three and nine months ended June 30, 2022, respectively.
Schedule of Restructuring Activities and Related Accruals	The following table summarizes the restructuring activities and related accrual for the nine months ended June 30, 2023: Utilized October 1, 2022 Charge to Cash June 30, Severance and related benefit costs $ 1.7 $ 4.1 $ (4.7) $ 1.1 Asset write-off and accelerated depreciation — 0.3 (0.3) — Consulting, project implementation and management, and other exit costs 0.8 4.7 (5.4) 0.1 Total restructuring activities and related accrual $ 2.5 $ 9.1 $ (10.4) $ 1.2

Earnings per Share (Tables)

Earnings per Share (Tables)	9 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Schedule of Weighted-Average Shares Outstanding	The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Basic weighted-average shares outstanding 51.1 52.5 51.3 53.5 Effect of dilutive securities: Options, RSE and PRSE awards 0.7 0.6 0.6 0.6 Total dilutive securities 0.7 0.6 0.6 0.6 Diluted weighted-average shares outstanding 51.8 53.1 51.9 54.1

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table sets forth goodwill by segment: Wet Sun and Skin Feminine Total Gross balance as of October 1, 2022 $ 1,133.5 $ 354.5 $ 205.2 $ 1,693.2 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance as of October 1, 2022 $ 764.5 $ 352.5 $ 205.2 $ 1,322.2 Changes in the nine months ended June 30, 2023 Cumulative translation adjustment 10.1 2.0 1.8 13.9 Gross balance as of June 30, 2023 $ 1,143.6 $ 356.5 $ 207.0 $ 1,707.1 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance as of June 30, 2023 $ 774.6 $ 354.5 $ 207.0 $ 1,336.1
Schedule of Amortizable Intangible Assets	The following table sets forth intangible assets by class: June 30, 2023 September 30, 2022 Carrying Accumulated Net Carrying Accumulated Net Indefinite lived Trade names and brands $ 595.4 $ — $ 595.4 $ 587.1 $ — $ 587.1 Amortizable Trade names and brands $ 339.7 $ 84.3 $ 255.4 $ 339.4 $ 72.2 $ 267.2 Technology and patents 78.6 76.1 2.5 77.8 75.0 2.8 Customer related and other 271.2 140.8 130.4 267.1 127.5 139.6 Amortizable intangible assets 689.5 301.2 388.3 684.3 274.7 409.5 Total intangible assets $ 1,284.9 $ 301.2 $ 983.7 $ 1,271.4 $ 274.7 $ 996.6

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	9 Months Ended
	Jun. 30, 2023
Supplemental Balance Sheet Information [Abstract]
Supplement Balance Sheet Information	June 30, September 30, Inventories Raw materials and supplies $ 88.8 $ 80.4 Work in process 95.8 103.2 Finished products 317.9 265.7 Total inventories $ 502.5 $ 449.3 Other Current Assets Prepaid expenses $ 73.4 $ 70.2 Value added tax receivables 48.0 52.7 Income taxes receivable 20.7 19.3 Other 15.1 25.1 Total other current assets $ 157.2 $ 167.3 Property, Plant and Equipment Land $ 18.7 $ 18.0 Buildings 142.8 140.3 Machinery and equipment 1,103.9 1,050.0 Capitalized software costs 59.4 56.5 Construction in progress 38.9 47.0 Total gross property, plant and equipment 1,363.7 1,311.8 Accumulated depreciation and amortization (1,023.9) (966.3) Total property, plant and equipment, net $ 339.8 $ 345.5 Other Current Liabilities Accrued advertising and sales promotion $ 55.2 $ 34.9 Other 265.8 256.8 Total other current liabilities $ 321.0 $ 291.7 Other Liabilities Pensions and other retirement benefits $ 58.8 $ 57.9 Other 111.2 115.7 Total other liabilities $ 170.0 $ 173.6

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Summary of Lease Information	A summary of the Company's lease information is as follows: June 30, September 30, Assets Classification Right of use assets Other assets $ 49.1 $ 50.1 Liabilities Current lease liabilities Other current liabilities $ 8.6 $ 8.8 Long-term lease liabilities Other liabilities 41.0 41.5 Total lease liabilities $ 49.6 $ 50.3 Other information Weighted-average remaining lease term (years) 11 10 Weighted-average incremental borrowing rate 7.0 % 6.6 % Three Months Ended Nine Months Ended 2023 2022 2023 2022 Statement of Earnings Lease expense (1) $ 3.0 $ 3.7 $ 9.1 $ 10.5 Other information Leased assets obtained in exchange for new lease liabilities $ 0.5 $ 1.0 $ 2.0 $ 3.9 Cash paid for amounts included in the measurement of lease liabilities $ 3.0 $ 3.7 $ 9.0 $ 10.7
Lessee, Operating Lease, Liability, Maturity	The Company's future lease payments, including reasonably assured renewal options under leases, are as follows: Lease liability repayments June 30, 2023 Remainder of fiscal 2023 $ 2.7 2024 10.3 2025 9.4 2026 8.0 2027 6.2 2028 and thereafter 40.4 Total future minimum lease commitments 77.0 Less: Imputed interest (27.4) Present value of lease liabilities $ 49.6

Debt (Tables)

Debt (Tables)	9 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt	The detail of long-term debt was as follows: June 30, September 30, Senior notes, fixed interest rate of 5.500%, due 2028 $ 750.0 $ 750.0 Senior notes, fixed interest rate of 4.125%, due 2029 500.0 500.0 U.S. revolving credit facility (1) 85.0 155.0 Total 1,335.0 1,405.0 Less unamortized debt issuance costs and discount (2) 11.9 13.6 Total long-term debt $ 1,323.1 $ 1,391.4 (1) The U.S. revolving credit facility matures in April 2025. (2) As of June 30, 2023, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $7.2 and $4.7, respectively. As of September 30, 2022, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $8.3 and $5.3, respectively.

Retirement Plans (Tables)

Retirement Plans (Tables)	9 Months Ended
	Jun. 30, 2023
Retirement Benefits [Abstract]
Schedule of Net Periodic Pension and Postretirement Cost (Benefit)	The Company’s net periodic pension and postretirement costs (income) for its material plans were as follows: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Service cost $ 0.5 $ 0.9 $ 1.4 $ 2.9 Interest cost 5.3 2.6 15.9 7.8 Expected return on plan assets (5.4) (5.3) (16.3) (15.9) Recognized net actuarial loss 0.4 1.5 1.2 4.6 Defined benefit settlement loss — — 7.2 — Net periodic cost (income) $ 0.8 $ (0.3) $ 9.4 $ (0.6)

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Jun. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Loss	The following table presents the changes in AOCI, net of tax, by component: Foreign Pension and Hedging Total Balance as of October 1, 2022 $ (131.2) $ (92.6) $ 7.7 $ (216.1) Other comprehensive income (loss), net of tax 67.6 (2.3) (1.5) 63.8 Reclassifications to earnings — 6.2 (4.7) 1.5 Balance as of June 30, 2023 $ (63.6) $ (88.7) $ 1.5 $ (150.8) Foreign Pension and Hedging Total Balance as of October 1, 2021 $ (41.8) $ (97.3) $ 2.2 $ (136.9) Other comprehensive (loss) income, net of tax (50.3) (2.6) 8.7 (44.2) Reclassifications to earnings — 3.4 (4.2) (0.8) Balance as of June 30, 2022 $ (92.1) $ (96.5) $ 6.7 $ (181.9)
Schedule of Reclassifications out of Accumulated Other Comprehensive Loss	The following table presents the reclassifications out of AOCI: Three Months Ended Nine Months Ended Affected Line Item in the Details of AOCI Components 2023 2022 2023 2022 Gain / (Loss) on cash flow hedges Foreign exchange contracts $ 1.0 $ 3.4 $ 6.8 $ 6.3 Other (income) expense, net Income tax expense (benefit) 0.3 1.1 2.1 2.1 Income tax provision 0.7 2.3 4.7 4.2 Amortization of defined benefit pension and postretirement items Actuarial losses (1) $ (0.4) $ (1.5) $ (1.2) $ (4.6) Defined benefit settlement loss — — (7.2) — Other (income) expense, net Income tax expense (benefit) (0.1) (0.4) (2.2) (1.2) Income tax provision (0.3) (1.1) (6.2) (3.4) Total reclassifications for the period $ 0.4 $ 1.2 $ (1.5) $ 0.8 (1) These AOCI components are included in the computation of net periodic cost. See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	9 Months Ended
	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Derivative Instruments	The following table provides estimated fair values of derivative instruments: Fair Value of Assets (Liabilities) as of (1) June 30, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 2.4 $ 11.3 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 1.5 $ 2.0 (1) Derivative assets are presented in Other current assets or Other assets. Derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Gains and Losses on Derivative Instruments	The following table provides the pre-tax amounts of gains and losses on derivative instruments: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in OCI (1) $ 3.7 $ 7.8 $ (2.1) $ 12.7 Gain reclassified from AOCI into income (1) (2) 1.0 3.4 6.8 6.3 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ 3.7 $ 0.3 $ 1.7 $ 2.0 (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk.
Schedule of Offsetting Assets and Liabilities	The following table provides financial assets and liabilities for balance sheet offsetting: As of June 30, 2023 As of September 30, 2022 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 5.5 $ (1.8) $ 13.4 $ (0.5) Gross amounts offset in the balance sheet — 0.2 — 0.4 Net amounts of assets (liabilities) presented in the balance sheet $ 5.5 $ (1.6) $ 13.4 $ (0.1) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: June 30, September 30, Assets (Liabilities) at estimated fair value: Deferred compensation liability $ (19.3) $ (21.8) Derivatives - foreign currency contracts (liability) asset 3.9 13.3 Net liabilities at estimated fair value $ (15.4) $ (8.5)

Segment Data (Tables)

Segment Data (Tables)	9 Months Ended
	Jun. 30, 2023
Segment Reporting [Abstract]
Schedule of Segment Sales and Profitability	Segment net sales and profitability are presented below: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Net Sales Wet Shave $ 324.1 $ 326.3 $ 908.0 $ 917.4 Sun and Skin Care 244.9 216.2 567.5 504.3 Feminine Care 81.0 81.3 242.0 213.1 Total net sales $ 650.0 $ 623.8 $ 1,717.5 $ 1,634.8 Segment Profit Wet Shave $ 32.1 $ 37.5 $ 102.6 $ 116.6 Sun and Skin Care 61.1 46.6 114.1 92.6 Feminine Care 13.9 8.8 37.7 19.1 Total segment profit 107.1 92.9 254.4 228.3 General corporate and other expenses (15.8) (14.8) (48.7) (42.8) Amortization of intangibles (7.8) (7.8) (23.2) (21.8) Interest and other expense, net (15.4) (13.6) (53.3) (43.8) Restructuring and related costs (1) (3.1) (3.9) (8.9) (9.8) Acquisition and integration costs (2) (1.0) (0.9) (5.1) (8.0) Sun Care reformulation costs (3) (0.6) (0.6) (1.7) (4.1) Defined benefit settlement loss (4) — — (7.2) — VAT settlement costs (5) — — — (3.4) Legal matters, net income (expense) (6) 6.8 7.5 6.3 7.5 SKU rationalization charges (7) — (22.5) — (22.5) Total earnings before income taxes $ 70.2 $ 36.3 $ 112.6 $ 79.6 (1) Restructuring and related costs of nil and $0.2 are included within Cost of products sold for the three and nine months ended June 30, 2023, respectively. Includes pre-tax SG&A of $0.1 and $0.2 for the three and nine months ended June 30, 2023, respectively and $0.4 and $0.6 for the three and nine months ended June 30, 2022. (2) Includes pre-tax SG&A of $0.9 and $7.2 for the three and nine months ended June 30, 2022, respectively, for the Acquisition. Additionally, includes Cost of products sold of $0.8 related to the valuation of acquired inventory for the Acquisition for the nine months ended June 30, 2022. See Note 2 of the Notes to Condensed Consolidated Financial Statements. (3) Includes pre-tax R&D of $0.6 and $1.7 for the three and nine months ended June 30, 2023, respectively, and pre-tax R&D of $0.6 for both the three and nine months ended June 30, 2022. Additional, includes pre-tax Cost of products sold of $3.5 for the nine months ended June 30, 2022 related to the reformulation, recall and destruction of certain Sun Care products. (4) Includes pre-tax loss of $7.2 for the nine months ended June 30, 2023 related the settlement of the Canada Plan. See Note 11 of the Notes to Condensed Consolidated Financial Statements. (5) Includes pre-tax SG&A of $3.4 for the nine months ended June 30, 2022 related to the estimated settlement of a prior years’ value-added tax audit of the Company’s German subsidiary. (6) Includes pre-tax SG&A of $7.1 for both the three and nine months ended June 30, 2023 and $7.5 for both the three and nine months ended June 30, 2022 for the favorable resolution of legal matters. See Note 16 of the Notes to Condensed Consolidated Financial Statements. Also includes other costs of $0.3 and $0.8 for the three and nine months ended June 30, 2023.
Schedule of Sales by Geographic Area	The following table presents the Company’s net sales by geographic area: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Net Sales to Customers United States $ 391.6 $ 392.8 $ 1,031.3 $ 997.2 International 258.4 231.0 686.2 637.6 Total net sales $ 650.0 $ 623.8 $ 1,717.5 $ 1,634.8
Schedule of Supplemental Product Information	Supplemental product information is presented below for net sales: Three Months Ended Nine Months Ended 2023 2022 2023 2022 Razors and blades $ 291.2 $ 290.1 $ 816.6 $ 821.1 Tampons, pads, and liners 81.0 81.3 242.0 213.1 Sun care products 184.2 162.4 385.8 334.0 Grooming products 38.2 33.9 123.5 114.6 Wipes and other skin care 22.5 19.9 58.2 55.7 Shaving gels and creams 32.9 36.2 91.4 96.3 Total net sales $ 650.0 $ 623.8 $ 1,717.5 $ 1,634.8

Background and Basis of Prese_2

Background and Basis of Presentation (Details) $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2023 country	Jun. 30, 2023 USD ($) country	Jun. 30, 2022 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which Edgewell operates	20	20
Number of countries with retail operations	50	50
Repayments of Revolving Credit Facility | $		$ 715	$ 413
Number of Reportable Segments	3

Business Combinations (Schedule

Business Combinations (Schedule of Recognized Identified Assets Acquired and Liabilities Assumed) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Sep. 30, 2022	Nov. 29, 2021
Business Acquisition [Line Items]
Goodwill acquired	$ 1,336.1	$ 1,322.2
Billie
Business Acquisition [Line Items]
Current assets acquired			$ 17
Goodwill acquired			181.2
Business combinations, intangible assets acquired			136
Property, plant and equipment acquired			3.2
Current liabilities assumed			(6.9)
Deferred tax liabilities acquired			(21.1)
Business combinations, assets acquired, goodwill and liabilities assumed, net			$ 309.4

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Millions		3 Months Ended	9 Months Ended
	Nov. 29, 2021	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Business Acquisition [Line Items]
Acquisition of Billie, net of cash acquired	$ 309.4		$ 0	$ 309.4
Business Acquisition, Pro Forma Information [Abstract]
Pro forma amortization expense				1.3
Pro forma acquisition costs		$ 0.9		$ 8
Billie
Business Acquisition [Line Items]
Weighted average useful life of acquired intangible assets	19 years

Business Combinations (Detail_2

Business Combinations (Details) - USD ($)	3 Months Ended	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2022
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Proforma net sales	$ 623.8	$ 1,644.8
Proforma net earnings	$ 31.6	$ 70.3

Restructuring Charges (Schedule

Restructuring Charges (Schedule of Charges Related to Restructuring Activities) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]
Severance Costs	$ 1.3	$ 1	$ 4.1	$ 4
Other Restructuring Costs	1.7	2.6	4.7	5.4
Restructuring and related costs	3.1	3.9	9.1	9.8
Restructuring Reserve	1.2		1.2		$ 2.5
Asset Impairment and Accelerated Depreciation	0.1	$ 0.3	0.3	$ 0.4
Asset Impairment and Accelerated Depreciation [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs			0.3
Restructuring Reserve	$ 0		$ 0		$ 0

Restructuring Charges (Schedu_2

Restructuring Charges (Schedule of Restructuring Activities and Related Accruals) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Restructuring Reserve [Roll Forward]
Beginning Balance			$ 2,500,000
Restructuring and related costs	$ 3,100,000	$ 3,900,000	9,100,000	$ 9,800,000
Utilized - Cash Payments			(10,400,000)
Ending Balance	1,200,000		1,200,000
Restructuring and Related Cost, Expected Cost	18		18
Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance			1,700,000
Restructuring and related costs			4,100,000
Utilized - Cash Payments			(4,700,000)
Ending Balance	1,100,000		1,100,000
Other Restructuring [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance			800,000
Restructuring and related costs			4,700,000
Utilized - Cash Payments			(5,400,000)
Ending Balance	100,000		100,000
Asset Impairment and Accelerated Depreciation [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance			0
Restructuring and related costs			300,000
Utilized - Cash Payments			(300,000)
Ending Balance	$ 0		$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income tax provision	$ 17.7	$ 5.8	$ 29.2	$ 14.7
Earnings before income taxes	$ 70.2	$ 36.3	$ 112.6	$ 79.6
Effective tax rate	25.30%	16.10%	25.90%	18.50%

Earnings per Share (Schedule of

Earnings per Share (Schedule of Weighted-Average Shares Outstanding) (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Schedule Of Weighted Average Number Of Shares [Line Items]
Basic weighted-average shares outstanding (in shares)	51.1	52.5	51.3	53.5
Effect of dilutive securities (in shares)	0.7	0.6	0.6	0.6
Diluted weighted-average shares outstanding (in shares)	51.8	53.1	51.9	54.1
RSE and PRSE awards
Schedule Of Weighted Average Number Of Shares [Line Items]
Effect of dilutive securities (in shares)	0.7	0.6	0.6	0.6
Share options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.8	1	1
RSE and PRSE awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0	0.5	0	0.3

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Schedule of Goodwill) (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2023	Sep. 30, 2022
Goodwill [Line Items]
Goodwill, Gross	$ 1,707.1	$ 1,693.2
Accumulated goodwill impairment loss	371	371
Goodwill [Roll Forward]
Beginning balance	1,322.2
Cumulative translation adjustment	(13.9)
Ending balance	1,336.1
Wet Shave
Goodwill [Line Items]
Goodwill, Gross	1,143.6	1,133.5
Accumulated goodwill impairment loss	369	369
Goodwill [Roll Forward]
Beginning balance	764.5
Cumulative translation adjustment	(10.1)
Ending balance	774.6
Sun and Skin Care
Goodwill [Line Items]
Goodwill, Gross	356.5	354.5
Accumulated goodwill impairment loss	2	2
Goodwill [Roll Forward]
Beginning balance	352.5
Cumulative translation adjustment	(2)
Ending balance	354.5
Feminine Care
Goodwill [Line Items]
Goodwill, Gross	207	205.2
Accumulated goodwill impairment loss	0	$ 0
Goodwill [Roll Forward]
Beginning balance	205.2
Cumulative translation adjustment	(1.8)
Ending balance	$ 207

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Schedule of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 689.5		$ 689.5		$ 684.3
Amortizable intangible assets, accumulated amortization	301.2		301.2		274.7
Amortizable intangible assets, net	388.3		388.3		409.5
Other intangible assets, net	983.7		983.7		996.6
Intangible Assets, Gross (Excluding Goodwill)	1,284.9		1,284.9		1,271.4
Amortization of intangibles	7.8	$ 7.8	23.2	$ 21.8
Amortizable intangible assets, amortization expense, remainder of 2023	7.7		7.7
Amortizable intangible assets, amortization expense, fiscal 2024	30.8		30.8
Amortizable intangible assets, amortization expense, fiscal 2025	30.7		30.7
Amortizable intangible assets, amortization expense, fiscal 2026	30.5		30.5
Amortizable intangible assets, amortization expense, fiscal 2027	30.5		30.5
Amortizable intangible assets, amortization expense, fiscal 2028	30.4		30.4
Amortizable intangible assets, amortization expense, after fiscal 2028	227.7		227.7
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	595.4		595.4		587.1
Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	339.7		339.7		339.4
Amortizable intangible assets, accumulated amortization	84.3		84.3		72.2
Amortizable intangible assets, net	255.4		255.4		267.2
Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	78.6		78.6		77.8
Amortizable intangible assets, accumulated amortization	76.1		76.1		75
Amortizable intangible assets, net	2.5		2.5		2.8
Customer related and other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	271.2		271.2		267.1
Amortizable intangible assets, accumulated amortization	140.8		140.8		127.5
Amortizable intangible assets, net	$ 130.4		$ 130.4		$ 139.6

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Jun. 30, 2023	Sep. 30, 2022
Inventories
Raw materials and supplies	$ 88.8	$ 80.4
Work in process	95.8	103.2
Finished products	317.9	265.7
Total inventories	502.5	449.3
Other Current Assets
Prepaid expenses	73.4	70.2
Value added tax receivables	48	52.7
Income taxes receivable	20.7	19.3
Other	15.1	25.1
Total other current assets	157.2	167.3
Property, Plant and Equipment
Land	18.7	18
Buildings	142.8	140.3
Machinery and equipment	1,103.9	1,050
Capitalized software costs	59.4	56.5
Construction in progress	38.9	47
Total gross property, plant and equipment	1,363.7	1,311.8
Accumulated depreciation and amortization	(1,023.9)	(966.3)
Total property, plant and equipment, net	339.8	345.5
Other Current Liabilities
Accrued advertising and sales promotion	55.2	34.9
Short term lease obligation	8.6	8.8
Other	265.8	256.8
Total other current liabilities	321	291.7
Other Liabilities
Pensions and other retirement benefits	58.8	57.9
Noncurrent lease obligation	41	41.5
Other	111.2	115.7
Total other liabilities	$ 170	$ 173.6

Leases (Summary of Lease Inform

Leases (Summary of Lease Information) (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Jun. 30, 2023		Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022
Leases [Abstract]
Operating lease, right-of-use asset	$ 49.1			$ 49.1		$ 50.1
Short term lease obligation	8.6			8.6		8.8
Noncurrent lease obligation	41			41		41.5
Total lease obligation	$ 49.6			$ 49.6		$ 50.3
Operating lease, weighted average remaining lease term	11 years			11 years		10 years
Operating lease, weighted average discount rate, percent	7%			7%		6.60%
Operating lease, expense	$ 3	[1]	$ 3.7	$ 9.1	$ 10.5
Right-of-use asset obtained in exchange for operating lease liability	0.5		1	2	3.9
Operating lease, payments	$ 3		$ 3.7	$ 9	$ 10.7
[1]Lease expense is included in Cost of products sold or SG&A expense based on the nature of the lease. Short-term lease expense is not considered material and is, therefore, excluded from this amount.

Leases (Operating Lease Payment

Leases (Operating Lease Payment Schedule) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Lessee, operating lease, payment due current year	$ 2.7
Lessee, operating lease, payment due year two	10.3
Lessee, operating lease, payment due year three	9.4
Lessee, operating lease, payment due year four	8
Lessee, operating lease, payment due year five	6.2
Lessee, operating lease, payment due after year five	40.4
Lessee, operating lease, payments due	77
Lessee, operating lease, undiscounted excess amount	27.4
Total lease obligation	$ 49.6	$ 50.3
Operating lease, weighted average remaining lease term	11 years	10 years

Accounts Receivable Facility (N

Accounts Receivable Facility (Narrative) (Details) - Accounts receivable sales agreement - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022
Transfer of Financial Assets Accounted for as Sales [Line Items]
Accounts receivable sold through AR Facility	$ 388.7	$ 354	$ 916.3	$ 791.2
Transfer of accounts receivable, sales amount derecognized	164.6		164.6		$ 78.7
Loss on sale of accounts receivable	$ 2.1	$ 0.6	$ 4.5	$ 1.1

Debt (Details)

Debt (Details) - USD ($)	Feb. 06, 2023	Jun. 30, 2023		Sep. 30, 2022
Debt Instrument [Line Items]
Total		$ 1,335,000,000		$ 1,405,000,000
Long-term debt		1,323,100,000		1,391,400,000
Notes payable		17,700,000		19,000,000
Unamortized debt issuance costs		11,900,000	[1]	13,600,000
Senior Secured Revolving Credit Facility
Debt Instrument [Line Items]
Debt Instrument, Issued, Principal	$ 425,000,000
Senior notes | Senior Notes, Due 2028
Debt Instrument [Line Items]
Total		750,000,000		750,000,000
Unamortized debt issuance costs		7,200,000		8,300,000
Senior notes | Senior Notes, Due 2029
Debt Instrument [Line Items]
Total		500,000,000		500,000,000
Unamortized debt issuance costs		4,700,000		5,300,000
Revolving credit facility
Debt Instrument [Line Items]
Total		$ 85,000,000	[2]	$ 155,000,000
[1]As of June 30, 2023, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $7.2 and $4.7, respectively. As of September 30, 2022, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $8.3 and $5.3, respectively.[2]The U.S. revolving credit facility matures in April 2025.

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Retirement Benefits [Abstract]
Service cost	$ 0.5	$ 0.9	$ 1.4	$ 2.9
Interest cost	5.3	2.6	15.9	7.8
Expected return on plan assets	(5.4)	(5.3)	(16.3)	(15.9)
Recognized net actuarial loss	0.4	1.5	1.2	4.6
Net periodic cost (income)	0.8	$ (0.3)	9.4	$ (0.6)
Defined benefit settlement loss	$ 0		$ 7.2

Equity (Details)

Equity (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions				3 Months Ended						9 Months Ended
	Aug. 01, 2023	May 08, 2023	Feb. 03, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2023	Jun. 30, 2022	Jan. 26, 2018
Equity [Abstract]
Share repurchase authorization												10
Treasury shares repurchased (in shares)										1.1
Treasury shares repurchased (in usd)				$ 15.2	$ 15	$ 15	$ 34.7	$ 50.9	$ 24.5	$ 45.2
Share repurchase authorization, remaining				5.4						5.4
Dividends declared										$ 23.9
Dividends to common shareholders										$ 23.8	$ 24.7
Dividends declared (per share)		$ 0.15	$ 0.15							$ 0.15
Dividends declared (per share)		$ 0.15	$ 0.15							$ 0.15
Subsequent Event
Equity [Abstract]
Dividends declared (per share)	$ 0.15
Dividends declared (per share)	$ 0.15

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ (216.1)	$ (136.9)
OCI before reclassifications	63.8	(44.2)
Reclassifications to earnings	1.5	(0.8)
Ending balance	(150.8)	(181.9)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(131.2)	(41.8)
OCI before reclassifications	67.6	(50.3)
Reclassifications to earnings	0	0
Ending balance	(63.6)	(92.1)
Pension and Post-retirement Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(92.6)	(97.3)
OCI before reclassifications	(2.3)	(2.6)
Reclassifications to earnings	6.2	3.4
Ending balance	(88.7)	(96.5)
Hedging Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	7.7	2.2
OCI before reclassifications	(1.5)	8.7
Reclassifications to earnings	(4.7)	(4.2)
Ending balance	$ 1.5	$ 6.7

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss (Schedule of Reclassifications out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions	3 Months Ended				9 Months Ended
	Jun. 30, 2023		Jun. 30, 2022		Jun. 30, 2023	Jun. 30, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amortization of defined benefit pension and postretirement items, settlement loss, before tax	$ 0				$ (7.2)
Reclassifications to earnings					(1.5)	$ 0.8
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax	1		$ 3.4
OCI Cash flow hedge, reclassification to earnings, tax	0.3		1.1		2.1	2.1
Other comprehensive income, reclassification to earnings, cash flow hedges, after tax	0.7		2.3		4.7	4.2
Amortization of defined benefit pension and postretirement items, actuarial losses, before tax	(0.4)	[1]	(1.5)	[1]	(1.2)	(4.6)
Amortization of defined benefit pension and postretirement items, tax	(0.1)		(0.4)		(2.2)	(1.2)
Amortization of defined benefit pension and postretirement items, after tax	(0.3)		(1.1)		(6.2)	(3.4)
Reclassifications to earnings	$ 0.4		$ 1.2		$ (1.5)	$ 0.8
[1]These AOCI components are included in the computation of net periodic cost. See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Narrative) (Details) $ in Millions	Jun. 30, 2023 USD ($) contracts	Sep. 30, 2022 USD ($)
Derivative [Line Items]
Long-term debt	$ 1,335	$ 1,405
Fixed rate
Derivative [Line Items]
Long-term debt	1,250	1,250
Fair value of long-term debt	$ 1,010.1	945.9
Not designated as hedge | FX contract
Derivative [Line Items]
Open foreign currency contracts | contracts	5
Derivative, notional amount	$ 34.6
Cash flow hedge | Designated as hedge | FX contract
Derivative [Line Items]
Estimated fair value of derivative	$ 2.4	$ 11.3
Open foreign currency contracts | contracts	64
Derivative, notional amount	$ 107.6

Financial Instruments and Ris_4

Financial Instruments and Risk Management (Schedule of Fair Values of Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		Jun. 30, 2023	Sep. 30, 2022
Not designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ 1.5	$ 2
Cash flow hedge | Designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ 2.4	$ 11.3
[1]erivative assets are presented in Other current assets or Other assets. Derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris_5

Financial Instruments and Risk Management (Schedule of Gains and Losses on Derivative Instruments) (Details) - USD ($) $ in Millions		3 Months Ended				9 Months Ended
		Jun. 30, 2023		Jun. 30, 2022		Jun. 30, 2023	Jun. 30, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]						Nonoperating Income (Expense)	Nonoperating Income (Expense)
FX contract | Designated as hedge | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI		$ 3.7	[1]	$ 7.8	[1]	$ (2.1)	$ 12.7
Gain (loss) reclassified from AOCI into income (effective portion)	[1],[2]					$ 1	$ 3.4
FX contract | Designated as hedge | Cash flow hedge | Other expense (income), net
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]
FX contract | Not designated as hedge | Other expense (income), net
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]
[1]Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk.[2]Gain was recorded in Other (income) expense, net.

Financial Instruments and Ris_6

Financial Instruments and Risk Management (Schedule of Offsetting Assets and Liabilities) (Details) - FX contract - USD ($) $ in Millions		Jun. 30, 2023	Sep. 30, 2022
Derivative [Line Items]
Gross amounts of recognized assets	[1]	$ 5.5	$ 13.4
Gross amounts of recognized liabilities	[2]	(1.8)	(0.5)
Gross amounts offset in the balance sheet	[1]	0	0
Gross amounts offset in the balance sheet	[2]	0.2	0.4
Net amounts of assets presented in the balance sheet	[1]	5.5	13.4
Net amounts of liabilities presented in the balance sheet	[2]	$ (1.6)	$ (0.1)
[1]All derivative assets are presented in Other current assets or Other assets.[2]All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris_7

Financial Instruments and Risk Management (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring fair value measurement - Level 2 - USD ($) $ in Millions	Jun. 30, 2023	Sep. 30, 2022
Derivative [Line Items]
Deferred compensation liability	$ (19.3)	$ (21.8)
Derivatives - foreign currency contracts (liability) asset	3.9	13.3
Net liabilities at estimated fair value	$ (15.4)	$ (8.5)

Segment Data (Schedule of Segme

Segment Data (Schedule of Segment Sales and Profitability) (Details) - USD ($) $ in Millions	3 Months Ended				9 Months Ended
	Jun. 30, 2023		Jun. 30, 2022		Jun. 30, 2023		Jun. 30, 2022
Segment Reporting Information [Line Items]
Net sales	$ 650		$ 623.8		$ 1,717.5		$ 1,634.8
Segment profit	85.6		49.9		173.1		123.4
SKU rationalization charges					0		(22.5)
Acquisition and integration costs	1	[1]	0.9	[1]	5.1		8
Sun Care reformulation costs	0.6		0.6	[2]	1.7		4.1
Defined Benefit Plan, Accumulated Benefit Obligation, (Increase) Decrease for Settlement and Curtailment	0				7.2
VAT settlement costs			0	[3]	0	[3]	(3.4)
Amortization of intangibles	7.8		7.8		23.2		21.8
Interest and other expense, net	15.4		13.6		53.3		43.8
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses	(3.1)		(3.9)		(8.9)		(9.8)
Earnings before income taxes	70.2		36.3		112.6		79.6
Gain (Loss) Related to Litigation Settlement	(6.8)		(6.3)		(7.5)		(7.5)
Wet Shave
Segment Reporting Information [Line Items]
Net sales	324.1		326.3		908		917.4
Segment profit	32.1		37.5		102.6		116.6
Sun and Skin Care
Segment Reporting Information [Line Items]
Net sales	244.9		216.2		567.5		504.3
Segment profit	61.1		46.6		114.1		92.6
Feminine Care
Segment Reporting Information [Line Items]
Net sales	81		81.3		242		213.1
Segment profit	13.9		8.8		37.7		19.1
Total Segments
Segment Reporting Information [Line Items]
Segment profit	107.1		92.9		254.4		228.3
Corporate
Segment Reporting Information [Line Items]
General corporate and other expenses	$ 15.8		$ 14.8		$ 48.7		$ 42.8
[1]Includes pre-tax SG&A of $0.9 and $7.2 for the three and nine months ended June 30, 2022, respectively, for the Acquisition. Additionally, includes Cost of products sold of $0.8 related to the valuation of acquired inventory for the Acquisition for the nine months ended June 30, 2022. See Note 2 of the Notes to Condensed Consolidated Financial Statements.[2]Includes pre-tax R&D of $0.6 and $1.7 for the three and nine months ended June 30, 2023, respectively, and pre-tax R&D of $0.6 for both the three and nine months ended June 30, 2022. Additional, includes pre-tax Cost of products sold of $3.5 for the nine months ended June 30, 2022 related to the reformulation, recall and destruction of certain Sun Care products.[3]Includes pre-tax SG&A of $3.4 for the nine months ended June 30, 2022 related to the estimated settlement of a prior years’ value-added tax audit of the Company’s German subsidiary. (6) Includes pre-tax SG&A of $7.1 for both the three and nine months ended June 30, 2023 and $7.5 for both the three and nine months ended June 30, 2022 for the favorable resolution of legal matters. See Note 16 of the Notes to Condensed Consolidated Financial Statements. Also includes other costs of $0.3 and $0.8 for the three and nine months ended June 30, 2023. (7) Includes pre-tax COGS of $22.5 for the three and nine months ended June 30, 2022 for the write-off of certain Wet Ones SKUs and related contract termination charges. Wet one products are included within the Sun and Skin Care segment.

Segment Data Segment Data (Sche

Segment Data Segment Data (Schedule of Sales by Geographical Area) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue from External Customer [Line Items]
Net sales	$ 650	$ 623.8	$ 1,717.5	$ 1,634.8
United States
Revenue from External Customer [Line Items]
Net sales	391.6	392.8	1,031.3	997.2
International
Revenue from External Customer [Line Items]
Net sales	$ 258.4	$ 231	$ 686.2	$ 637.6

Segment Data (Schedule of Suppl

Segment Data (Schedule of Supplemental Product Information) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue from External Customer [Line Items]
Net sales	$ 650	$ 623.8	$ 1,717.5	$ 1,634.8
Razors and blades
Revenue from External Customer [Line Items]
Net sales	291.2	290.1	816.6	821.1
Tampons, pads and liners
Revenue from External Customer [Line Items]
Net sales	81	81.3	242	213.1
Sun care products
Revenue from External Customer [Line Items]
Net sales	184.2	162.4	385.8	334
Grooming products
Revenue from External Customer [Line Items]
Net sales	38.2	33.9	123.5	114.6
Wipes and other skin care products
Revenue from External Customer [Line Items]
Net sales	22.5	19.9	58.2	55.7
Shaving gels and creams
Revenue from External Customer [Line Items]
Net sales	$ 32.9	$ 36.2	$ 91.4	$ 96.3

Commitment and Contingencies (D

Commitment and Contingencies (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure	Commitments and Contingencies Legal Proceedings During the three months ended June 30, 2023 the Company settled a legal matter which resulted in a gain of $4.9 related to an intellectual property claim against a third party. This was included in SG&A in the Condensed Consolidated Statements of Earnings and Comprehensive Income . The Company received payment for the intellectual property claim settlement during the three months ended June 30, 2023. Additionally, during the three months ended June 30, 2023, the Company received a favorable court ruling regarding an international VAT matter, which the plaintiff has no ability to appeal. As the Company had previously recorded an accrual for this matter, based on its best estimate of the facts and circumstances at that time, the result of the favorable court ruling was a release of the reserve established which resulted in a gain of $2.2. This was included in SG&A in the Condensed Consolidated Statements of Ear nings and Comprehensive Income . During the three months ended June 30, 2022 the Company settled certain legal matters which resulted in a gain of $7.5 related to intellectual property claims against a third party. This was included in SG&A in the Condensed Consolidated Statements of Earnings and Comprehensive Income . The Company received payment for the settlement subsequent to June 30, 2022.
Other Commitments [Line Items]
Gain (Loss) Related to Litigation Settlement	$ 6.8	$ 6.3	$ 7.5	$ 7.5
VAT matter
Other Commitments [Line Items]
Gain (Loss) Related to Litigation Settlement	2.2
intellectual property claim against a third party
Other Commitments [Line Items]
Gain (Loss) Related to Litigation Settlement	$ 4.9	$ 7.5